Breakthrough in orthotopic cardiac xenotransplantation (oXHTx): completion of the preclinical life-supporting pig-to-baboon oXHTx study with first successful long-term survival (terminated on day 90 and up to 195 days) in 6 of 8 cases using CD40mAb costimulation blockade for immunosuppression